TOMI Environmental Solutions Reports Record Corporate Service Revenue
TOMI Environmental Solutions, Inc. (NASDAQ: TOMZ), a globally recognized leader in disinfection and decontamination technologies, has recently unveiled an impressive achievement in their iHP Corporate Service division. This division is projected to generate revenues nearing $650,000 for the three months that concluded at the end of September 2024. This remarkable figure not only sets a new record for quarterly performance within this subsidiary but also significantly surpasses the historical quarterly average of about $250,000, which translates to approximately $1 million annually.
Growth Drivers in Q3
The substantial growth observed in the third quarter is largely attributed to an increase in demand for TOMI's specialized iHP services, particularly within the life sciences sector. The company has made notable strides in expanding its market share, fortifying its leadership position in delivering thorough solutions across various environments. Through ongoing strategic initiatives, TOMI Environmental Solutions is well poised for further expansion in this thriving sector.
Leadership Insights
“Our iHP Corporate Service has emerged as a key revenue driver,” stated E.J. Shane, Chief Operating Officer of TOMI Environmental Solutions. “The faith that the life sciences industry has placed in our technology, merged with our upgraded product capabilities and skilled technicians, has fostered substantial growth this past quarter. Additionally, we have observed that some competitors have exited the market, which opens up more opportunities for TOMI to capture additional market share.”
Strategic Contracts Fueling Growth
TOMI's momentum is further reinforced by several multi-year service contracts with prominent organizations. Key agreements include:
Major Contracts Secured
- MD Anderson Cancer Center (three-year contract)
- LFB USA, a leader in pharmaceutical bioproducts, contracted for biannual decontamination
- Pfizer, TOMI's initial significant player in global biopharma for routine services
- EMAQ Partnership, providing service for additional Pfizer facilities while ensuring demand for BIT solutions and brand awareness
Future Outlook for TOMI
“As diverse industries increasingly adopt the SteraMist iHP technology for critical disinfection protocols, we anticipate a sustained growth in service demand,” added Dr. Halden S. Shane, CEO of TOMI Environmental Solutions. “The recent contracts awarded to us and the ongoing expansion of service operations positions us ideally to accelerate sales across a variety of industries.”
About TOMI Environmental Solutions, Inc.
TOMI Environmental Solutions, Inc. is a pioneer in decontamination and infection prevention technologies, driven by innovative environmental solutions for disinfection. The company specializes in manufacturing, sales, and licensing of its leading Binary Ionization Technology (BIT) platform. This technology, initially developed under a defense grant associated with the Defense Advanced Research Projects Agency (DARPA) of the U.S. Department of Defense, employs a low concentration of hydrogen peroxide as its sole active element while utilizing patented ionized Hydrogen Peroxide (iHP) technology in all SteraMist systems to deliver exceptional disinfection results.
TOMI products cater to a wide array of uses, servicing locations such as hospitals, biosafety labs, pharmaceutical manufacturing sites, commercial properties, educational institutions, and emergency response facilities.
Contact Information
For more information, please reach out to us at info@tomimist.com.
Frequently Asked Questions
What are the recent revenue figures for TOMI's iHP division?
TOMI Environmental Solutions has reported expected revenues of around $650,000 for the recent quarter, setting a new record for their iHP Corporate Service division.
Which sectors are driving the growth for TOMI?
The rising demand is particularly strong within the life sciences sector, contributing significantly to TOMI's revenue growth.
What strategic contracts has TOMI secured recently?
TOMI has established contracts with MD Anderson Cancer Center, LFB USA, Pfizer, and EMAQ Partnership, showcasing their robust client portfolio.
How does TOMI plan to sustain its growth trajectory?
TOMI plans to leverage the continued adoption of their SteraMist iHP technology and expand their service operations to enhance sales across various industries.
Where can I learn more about TOMI Environmental Solutions?
Information and updates regarding TOMI can be found on their official website and through their contact email information.
